Not logged in Share Save
Long-Term Health-Related Quality of Life in People Living with HIV Who Present to Care with AIDS or Severe Immunodeficiency: The CoRIS AIDS Survivors Study Portilla-Tamarit, J; Fuster-RuizdeApodaca, MJ; Portilla-Tamarit, I; Reus, S; Riera, M; Espinosa, N; Martin, J; Bernal, E; Masia, M; Calzado, S; Portilla, J Share Save
Dolutegravir/Lamivudine Efficacy and Safety Outcomes in People With HIV-1 With or Without Historical Resistance Results at Screening: 48-Week Pooled Analysis Scholten, Stefan; Cahn, Pedro; Portilla, Joaquin; Bisshop, Fiona; Hodder, Sally; Ruane, Peter; Kaplan, Richard; Wynne, Brian R.; Man, Choy Y.; Grove, Richard; Wang, Ruolan; Jones, Bryn; Ait-Khaled, Mounir; Kisare, Michelle; Okoli, Chinyere Share Save
Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients With HIV Berenguer, Juan; Jarrin, Inmaculada; Bellon, Jose M.; Diez, Cristina; Jimenez-Sousa, Maria A.; Lopez, Juan C.; Pinto-Martinez, Adriana; Moreno, Santiago; Montes, Maria L.; Iribarren, Jose A.; Orviz, Eva; Portilla, Joaquin; Villarroya, Francesc; Domingo, Pere; Resino, Salvador Share Save
A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes Santos, Jose R.; Domingo, Pere; Portilla, Joaquin; Gutierrez, Felix; Imaz, Arkaitz; Vilchez, Helem; Curran, Adria; Valcarce-Pardeiro, Nieves; Payeras, Antoni; Bernal, Enrique; Montero-Alonso, Marta; Yzusqui, Miguel; Clotet, Bonaventura; Videla, Sebastia; Molto, Jose; Paredes, Roger Share Save
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens Podzamczer, Daniel; Imaz, Arkaitz; Lopez-Lirola, Ana; Knobel, Hernando; Masia, Mar; Fanciulli, Chiara; Hernandez, Cristina; Lagarde, Maria; Gutierrez, Angela; Curran, Adria; Morano, Luis; Montero-Alonso, Marta; Troya, Jesus; Rigo, Raul; Casadella, Maria; Navarro-Alcaraz, Antonio; Ardila, Fernando; Parera, Mariona; Bernal, Enrique; Echeverria, Patricia; Estrada, Vicente; Hidalgo-Tenorio, Carmen; Macias, Juan; Prieto, Paula; Portilla, Joaquin; Valencia, Eulalia; Vivancos, Maria Jesus; Rivero, Antonio Share Save
Low CD4/CD8 ratio is associated with increased morbidity and mortality in late and non-late presenters: results from a multicentre cohort study, 2004-2018 Dominguez-Dominguez, Lourdes; Rava, Marta; Bisbal, Otilia; Lopez-Cortes, Luis; Portilla, Joaquin; Podzamczer, Daniel; Olalla, Julian; Fuster, Daniel; Rubio, Rafael; Jarrin, Inmaculada; Iribarren, Jose Antonio; Moreno, Santiago Share Save
Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens Serrano-Villar, Sergio; Lopez-Huertas, Maria Rosa; Jimenez, Daniel; Galera, Carlos; Martinez-Sanz, Javier; Moreno, Elena; Muriel, Alfonso; Gutierrez, Felix; Busca, Carmen; Portilla, Joaquin; Bisbal, Otilia; Iribarren, Jose Antonio; Tejerina, Francisco; de los Santos, Ignacio; Moreno, Santiago Share Save
Efficacy and Safety of Switching to Dolutegravir/Lamivudine Versus Continuing a Tenofovir Alafenamide-Based 3-or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Results Through Week 144 From the Phase 3, Noninferiority TANGO Randomized Trial Osiyemi, Olayemi; De Wit, Stephane; Ajana, Faiza; Bisshop, Fiona; Portilla, Joaquin; Routy, Jean-Pierre; Wyen, Christoph; Ait-Khaled, Mounir; Leone, Peter; Pappa, Keith A.; Wang, Ruolan; Wright, Jonathan; George, Nisha; Wynne, Brian; Aboud, Michael; van Wyk, Jean; Smith, Kimberly Y. Share Save
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57) Podzamczer, D.; Mican, R.; Tiraboschi, J.; Portilla, J.; Domingo, P.; Llibre, J. M.; Ribera, E.; Vivancos, M. J.; Morano, L.; Masia, M.; Gomez, C.; Fanjul, F.; Payeras, A.; Inciarte, A.; Estrada, V; Rivero, A.; Castro, A.; Bernal, E.; Vinuesa, D.; Knobel, H.; Troya, J.; Macias, J.; Montero, M.; Sanz, J.; Navarro-Alcaraz, A.; Caicedo, A.; Fernandez, G.; Martinez, E.; Moreno, S. Share Save
Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort Berenguer, Juan; Diez, Cristina; Martin-Vicente, Maria; Mican, Rafael; Perez-Elias, Maria J.; Garcia-Fraile, Lucio J.; Vidal, Francisco; Suarez-Garcia, Ines; Podzamczer, Daniel; Del Romero, Jorge; Pulido, Federico; Iribarren, Jose A. .; Gutierrez, Felix; Poveda, Eva; Galera, Carlos; Izquierdo, Rebeca; Asensi, Victor; Portilla, Joaquin; Lopez, Juan C.; Arribas, Jose R.; Moreno, Santiago; Gonzalez-Garcia, Juan; Resino, Salvador; Jarrin, Inmaculada Share Save
Latin American Origin Is Not Associated with Worse Outcomes among Hospitalized Patients with COVID-19 in a Public Healthcare System Otero-Rodriguez, Silvia; Moreno-Perez, Oscar; Ramos, Jose Manuel; Garcia, Mar; Boix, Vicente; Reus, Sergio; Torrus, Diego; Chico-Sanchez, Pablo; Sanchez-Paya, Jose; Aldana-Macias, Fernando; Gil, Joan; Portilla, Joaquin; Merino, Esperanza Share Save
Share Save
Share Save
Share Save
Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping Casadella, M.; Santos, J. R.; Noguera-Julian, M.; Mican-Rivera, R.; Domingo, P.; Antela, A.; Portilla, J.; Sanz, J.; Montero-Alonso, M.; Navarro, J.; Masia, M.; Valcarce-Pardeiro, N.; Ocampo, A.; Perez-Martinez, L.; Pasquau, J.; Vivancos, M. J.; Imaz, A.; Carmona-Oyaga, P.; Munoz-Medina, L.; Villar-Garcia, J.; Barrufet, P.; Paredes, R. Share Save
Share Save
Effectiveness of boosted darunavir plus rilpivirine in patients with long-lasting HIV-1 infection: DARIL study Navarro, Jordi; Gonzalez-Cordon, Ana; Casado, Jose Luis; Bernardino, Jose I.; Domingo, Pere; Portilla, Joaquin; Maria Llibre, Josep; Colomer, Joan; Rial-Crestelo, David; Vizcarra, Pilar; Curran, Adria; Martinez, Esteban; Ribera, Esteban Share Save
The algorithm used for the interpretation of doravirine transmitted drug resistance strongly influences clinical practice and guideline recommendations Guerrero-Beltran, Carlos; Martinez-Sanz, Javier; Alvarez, Marta; Olalla, Julian; Garcia-Alvarez, Monica; Antonio Iribarren, Jose; Masia, Mar; Montero, Marta; Garcia-Bujalance, Silvia; Ramon Blanco, Jose; Rivero, Maria; Jesus Garcia-Fraile, Lucio; Espinosa, Nuria; Rodriguez, Carmen; Aguilera, Antonio; Carmen Vidal-Ampurdanes, Maria; Martinez, Marina; Iborra, Asuncion; Imaz, Arkaitz; Luis Gomez-Sirvent, Juan; Peraire, Joaquim; Portilla, Joaquin; Caballero, Estrella; Alejos, Belen; Garcia, Federico; Moreno, Santiago Share Save
Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose 2-Drug Regimen vs Continuing a Tenofovir Alafenamide-Based 3-or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Phase 3, Randomized, Noninferiority TANGO Study van Wyk, Jean; Ajana, Faiza; Bisshop, Fiona; De Wit, Stephane; Osiyemi, Olayemi; Sogorb, Joaquin Portilla; Routy, Jean-Pierre; Wyen, Christoph; Ait-Khaled, Mounir; Nascimento, Maria Claudia; Pappa, Keith A.; Wang, Ruolan; Wright, Jonathan; Tenorio, Allan R.; Wynne, Brian; Aboud, Michael; Gartland, Martin J.; Smith, Kimberly Y. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
